14-day Premium Trial Subscription Try For FreeTry Free
$0.390
-0.0015 (-0.383%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Clene Inc. prices

Date Open High Low Close Volume
Nov 07, 2023 $0.394 $0.449 $0.380 $0.420 431 624
Nov 06, 2023 $0.408 $0.408 $0.388 $0.389 326 702
Nov 03, 2023 $0.385 $0.416 $0.377 $0.404 615 523
Nov 02, 2023 $0.378 $0.388 $0.365 $0.388 364 142
Nov 01, 2023 $0.391 $0.391 $0.358 $0.378 367 934
Oct 31, 2023 $0.410 $0.413 $0.381 $0.390 345 603
Oct 30, 2023 $0.425 $0.425 $0.392 $0.405 536 777
Oct 27, 2023 $0.438 $0.438 $0.405 $0.417 456 798
Oct 26, 2023 $0.435 $0.435 $0.416 $0.420 459 015
Oct 25, 2023 $0.456 $0.456 $0.430 $0.433 277 581
Oct 24, 2023 $0.470 $0.494 $0.434 $0.434 417 156
Oct 23, 2023 $0.500 $0.500 $0.476 $0.480 159 396
Oct 20, 2023 $0.500 $0.500 $0.480 $0.498 137 220
Oct 19, 2023 $0.490 $0.501 $0.481 $0.490 91 301
Oct 18, 2023 $0.500 $0.519 $0.461 $0.497 235 435
Oct 17, 2023 $0.504 $0.526 $0.487 $0.490 510 262
Oct 16, 2023 $0.530 $0.530 $0.490 $0.520 334 545
Oct 13, 2023 $0.514 $0.527 $0.486 $0.509 213 033
Oct 12, 2023 $0.543 $0.543 $0.475 $0.501 390 433
Oct 11, 2023 $0.520 $0.550 $0.493 $0.526 315 024
Oct 10, 2023 $0.530 $0.535 $0.500 $0.528 188 505
Oct 09, 2023 $0.524 $0.530 $0.500 $0.528 193 301
Oct 06, 2023 $0.550 $0.557 $0.513 $0.540 340 136
Oct 05, 2023 $0.516 $0.660 $0.484 $0.543 2 712 053
Oct 04, 2023 $0.470 $0.513 $0.460 $0.494 258 090
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
BBCA May 03 0.99% $65.44
INVH May 03 0.90% $34.39
BNDX May 03 0.247% $48.68
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT